KAHR medical

Biotechnology, Medical, Pharmaceutical

Founded in 1/1/05

Jerusalem, Yerushalayim, Israel

http://www.kahrbio.com

For Profit

About KAHR medical

KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment options for cancer and autoimmune disorders.

Company Metrics

Employees: 1-10
Monthly Visits: None
Tech Stack: 7 active products

Financial Information

Estimated Revenue: $1M to $10M
Total Funding: 101450000 USD
Last Funding: 12500000 USD (Venture - Series Unknown)
Funding Status:

Technology Stack

KAHR medical actively uses 7 products in their tech stack.

Market Presence

Industries: Biotechnology, Medical, Pharmaceutical

Headquarters: Jerusalem, Yerushalayim, Israel

Employees